Tariq Kassum jumps from Obsidian to Celsius helm; Quell Therapeutics taps Iain McGill as new CEO
→ Cambridge, Massachusetts-based Celsius Therapeutics — which was launched in 2018 and backed by Third Rock Ventures and GV — has tapped Tariq Kassum to the helm. Kassum succeeded Alexis Borisy, who has been interim CEO and who stay as chairman of the board of directors.
Borisy recently made an unexpected exit from Third Rock, before their record $770 million fund for its next wave of investments in the life science field.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.